Home/ Supplements/ Electrolytes/ Trifibe SAP-340

Trifibe SAP-340

product on market Powder NFH Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile consists of basic macronutrients and calcium, which provide foundational energy and support bone health. There is strong evidence for the roles of protein and calcium in maintaining physiological function. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Trifibe SAP-340
Open Full PDF View on NIH DSLD →
Details

Label Data

10 Gram(s)
Serving Size
34
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
Total Carbohydrates
7 Gram(s) (3% DV)
Protein
1 Gram(s)
Calcium
7.8 mg (1% DV)
Iron
0.6 mg (3% DV)
16.25 mg (4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
0.4 mg (4% DV)
Market median: 18.0mg (1009 products) 263 studies (A:6, B:134)
Potassium
45.5 mg (1% DV)
6.5 Gram(s)
Market median: 100.0mg (1 products) 42 studies (A:1, B:15)
Psyllium husk powder
2.5 Gram(s)
Market median: 450.0mg (42 products)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: Adults: Stir 2 rounded tablespoons (approximately equal to 10 g) into 8 oz. (250 ml) of water or juice once or twice daily or as directed by your healthcare practitioner. Follow immediately with another 8 oz. (250 ml) of water or juice. Consume plenty of water or juice daily while using Trifibe-340.

If you are taking other medications, take this product 1 hour before or after them.

Warnings & Precautions

Not taking plenty of fluids may result in choking and/or blockage of the throat, esophagus or intestine and may cause constipation.

Do not take immediately before going to bed.

Cautions and warnings: Consult a healthcare practitioner prior to use if you are pregnant or breast-feeding or if you have diabetes.

Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported.

Notice: Do not eat this product if you have difficulty swallowing.

Known adverse reactions: If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product, seek immediate medical attention.

Do not use if seal is broken.

Keep out of reach of children.

Formulation Notes

Trifibe SAP-340 is a viscous 3-fiber blend of oat beta-glucan, psyllium husk, and glucomannan designed to support healthy cholesterol levels, blood glucose levels, and weight management, promoting cardiovascular health.

Trifibe SAP-340 helps to maintain gut regularity and intestinal health.

All ingredients listed for this product lot number have been tested by a third-party laboratory for identity, potency, and purity.

Trifibe SAP-340 will thicken if left standing.

Contains no: Soy, corn, eggs, dairy, yeast, citrus, preservatives, artificial flavor or color, starch, or sugar.

This product is non-GMO and vegan friendly.

This product is non-GMO and vegan friendly.

Color and smell may vary from one lot to another.

Fiber

Maintains gut regularity

Additional Information

NPN 80028868

Metadata

Product Details

UPC / SKU8 56711 00111 5
DSLD Entry Date2022-08-23
Product TypeOther Combinations
FormPowder
BrandNFH
DSLD ID272783
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.